首页 › 基金 › GOLDENTREE ASSET MANAGEMENT LP › COLL

GOLDENTREE ASSET MANAGEMENT LP 对 COLL 的持仓历史

COLLEGIUM PHARMACEUTICAL INC · 医疗保健

GOLDENTREE ASSET MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 COLL(COLLEGIUM PHARMACEUTICAL INC)744,889 股,市值约 US$26.9M,约占其申报组合的 1.57%,在其申报持仓中市值排名第 21 位。 GOLDENTREE ASSET MANAGEMENT LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)744.89K 股
申报持仓市值$26.92M
组合权重1.57%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

GOLDENTREE ASSET MANAGEMENT LP 对 COLL 的持仓演变

GOLDENTREE ASSET MANAGEMENT LP 于 Q2 2026 首次披露 COLL 持仓:744,889 股(约 US$26.9M)。

逐季持仓明细

季度股数金额变化
Q2 2026 744.89K $26.92M 新进

关于 COLL 与 13F 数据

COLL(COLLEGIUM PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 COLL,申报仓位最大的包括:TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), EVENTIDE ASSET MANAGEMENT, LLC (US$49.3M), SILVERBACK ASSET MANAGEMENT LLC (US$18.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 COLL 的基金

查看 COLL 的全部基金持有人 →

常见问题

How long has GOLDENTREE ASSET MANAGEMENT LP held COLL?

GOLDENTREE ASSET MANAGEMENT LP has disclosed COLL holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is GOLDENTREE ASSET MANAGEMENT LP's current position in COLL?

As of Q2 2026, GOLDENTREE ASSET MANAGEMENT LP holds 744.89K shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $26.92M, representing 1.57% of its reported portfolio and ranking #21.

Has GOLDENTREE ASSET MANAGEMENT LP been buying or selling COLL?

In the latest 13F filing (Q2 2026), GOLDENTREE ASSET MANAGEMENT LP newly opened its position in COLL.

Which other funds hold COLL?

Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., EVENTIDE ASSET MANAGEMENT, LLC, SILVERBACK ASSET MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.